Aaron Basile's  Instablog

Aaron Basile
Send Message
Contrarian Investor, Commodities Speculator, Technical Trader.
My blog:
Aaron Basile
  • Jazz Pharm. up 15% since suggestion 4 comments
    Sep 1, 2010 9:34 PM | about stocks: JAZZ


    Jazz Pharmaceuticals (NASDAQ:JAZZ) is up over 15% since I suggested it as a risk play one week ago on August 23rd. I pegged it for oversold on headlines as it has since gained back half of its share price before the selloff. Perhaps if you bought the stock when I suggested it, you made away with some attractive profits.

    Happy trading and hopefully I will get to recommending another risk play soon.

    Stocks: JAZZ
Back To Aaron Basile's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (4)
Track new comments
  • Justin M. Hall
    , contributor
    Comments (748) | Send Message


    Nice call, here!


    6 Sep 2010, 04:30 AM Reply Like
  • Justin M. Hall
    , contributor
    Comments (748) | Send Message
    Well, I tried to edit my last response to ask you some additional questions, but it timed out.


    Nevertheless, I still wanted to ask you a few questions with regards to econ, trading, investing, etc.


    If you do not oppose, then please drop me an email at HiRxInvestor@aol.com and I will forward you the questions I wanted to ask you.


    Whenever you have time, I hope you will also visit my [new] site at www.rxinvestors.com/.


    As it appears that you may have some interest in small cap biotech and pharma companies, you might also watch or follow these three cancer drug makers: OXGN, EPCT and SPPI.


    Disclosure: Of the three, I am and plan to remain a holder of and long-term investor (Think: 2012) in SPPI. I own positions in both common shares & LEAPS or long-term options in SPPI. While I do not own OXGN and EPCT, I have covered these companies in the recent past and believe both represent very good opportunities while trading with such low market values.


    Please keep in touch.


    6 Sep 2010, 05:13 AM Reply Like
  • Aaron Basile
    , contributor
    Comments (92) | Send Message
    Author’s reply » I like biotech long term. Peak oil might come sooner than we all think with all the new regulations on business. Oil is expensive enough just to explore.... EpiCept looks like a decent speculative play, volume is low and I need liquidity so I wouldn't be interested in trading the stock, but if they're market cap increases it's worth keeping an eye on.
    7 Sep 2010, 05:09 PM Reply Like
  • Justin M. Hall
    , contributor
    Comments (748) | Send Message
    At this point, EPCT is a value play and should be viewed as a buy out target.


    Regarding energy plays, I prefer natural gas. I am not a big fan of investing or trading the Oil. In fact, I have never recommended it. I do agree with you, Oil may be "expensive" now, and will likely come back some. Typically this is exactly how Oil has been traded over the years, i.e. Oil sells off during the fall and early winter months. This means, a better entry point will likely be found at or near year-end. Hope that makes sense.


    Keep in touch.


    9 Sep 2010, 09:44 PM Reply Like
Full index of posts »
Latest Followers


  • UUP Jun 11 $22 up 50%
    May 23, 2011
  • AG - much needed reversal
    Apr 6, 2011
  • MCPIQ continues breakout on Chinese quota cut!
    Mar 25, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.